A new treatment for breast cancer en route!

By: Dr. Steve Salvatore, Co-Owner of The Academy

An experimental breast cancer drug is showing promise in fighting triple negative breast cancer, a particularly aggressive form of the disease that’s hard to treat.  15% of all breast cancers are of the triple negative type.  The drug, known as “BSI-201” for now, is proving effective.  Up until now, drugs such as Herceptin or hormone therapy had little effect against triple negative breast cancer.  Oncologists are calling BSI-201 “the most exciting potential treatment in a long time”.  Currently, the drug is being tested in a major clinical trial.


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s